PETER T SCARDINO, MD
Urology at York Ave, New York, NY

License number
New York 210290
Category
Radiology
Type
Urology
Address
Address
1275 York Ave, New York, NY 10021
Phone
(212) 639-2000

Personal information

See more information about PETER T SCARDINO at radaris.com
Name
Address
Phone
Peter Scardino, age 79
25 Sutton Pl S APT 11G, New York, NY 10022
(212) 628-6129
Peter Scardino, age 70
58 West Blvd, East Rockaway, NY 11518
(516) 729-9206
Peter Scardino
62 Jonathan Dr, Mahopac, NY 10541
Peter Scardino
New York, NY
(212) 535-3985
Peter T Scardino, age 79
345 68Th St, Manhattan, NY 10001
(212) 535-3985
(212) 628-6129

Organization information

See more information about PETER T SCARDINO at bizstanding.com

Peter T Scardino MD

1275 York Ave #65, New York, NY 10065

Categories:
Physicians & Surgeons
Phone:
(212) 639-2000 (Phone)

Professional information

See more information about PETER T SCARDINO at trustoria.com
Peter Scardino Photo 1
Dr. Peter Scardino, New York NY - MD (Doctor of Medicine)

Dr. Peter Scardino, New York NY - MD (Doctor of Medicine)

Specialties:
Urology
Address:
MSKCC SURGERY GROUP
1275 York Ave, New York 10065
(800) 525-2225 (Phone)
MSKCC
1275 York Ave, New York 10065
(866) 425-8999 (Phone)
Certifications:
Urology, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
MSKCC SURGERY GROUP
1275 York Ave, New York 10065
MSKCC
1275 York Ave, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
Philosophy:
As Chairman of the Department of Surgery, I oversee a department widely recognized for its expertise and innovation in cancer surgery. In addition to my administrative responsibilities, I am a surgeon specializing in prostate cancer. My expertise is in early detection, prognosis, and surgical treatment of prostate cancer. Radical prostatectomy -- complete removal of the prostate -- can cure many men with prostate cancer. Our team has developed surgical techniques to preserve urinary and sexual function after prostatectomy, and we continue to seek ways to improve quality of life for patients after treatment. Not all prostate cancers progress in the same way. Many cancers pose little or no threat to life and health, while others grow aggressively and are resistant to treatment. My colleagues and I have pioneered the use of statistical models to predict both the natural progression of prostate cancer and how it will respond to treatment. These predictive tools (nomograms) help us tailor treatment for individual men according to the specific characteristics of their cancer. Today, nomograms are being used to help physicians and patients make medical decisions regarding a variety of other cancers, including pancreatic, lung, and breast cancer. Our prediction tools are available on our Web site at Prediction Tools. In 2001, I received an NIH grant to establish an ongoing Specialized Program of Research Excellence (SPORE) in prostate cancer at MSKCC. Our SPORE has an ambitious research program focused on developing therapies appropriate for patients with different types of prostate cancer at different stages of development. We hope to achieve this by using molecular and genetic data to improve our prediction models for prostate cancer, identifying the critical mechanisms by which prostate cancer grows and spreads, and developing drugs and immunological techniques for treatment-resistant metastatic cancers. My position at MSKCC includes appointments as Head of the Prostate Cancer Program and as the Florence and Theodore Baumritter/Enid Ancell Chair of Urologic Oncology. I am also a Professor in the Department of Urology at the Weill Medical College of Cornell University and at the State University of New York Downstate Medical Center. I have written many articles and book chapters and edited the Comprehensive Textbook of Genitourinary Oncology. In 2005, with Judith Kelman, I wrote Dr. Peter Scardino's Prostate Book, a guide to prostate cancer, prostatitis, and benign prostate hyperplasia (BPH). I serve as Editor-in-Chief of Nature Clinical Practice Urology, and I am an editorial board member and reviewer for several peer-reviewed journals. I am an active member of the National Academy of Sciences' Institute of Medicine and the American Urological Association.
Education:
Medical School
Duke University School Of Medicine
Graduated: 1971
Massachusetts General Hospital
University of California-Los Angeles
NCI


Peter Scardino Photo 2
Director Of Sales At Oxford Apparel

Director Of Sales At Oxford Apparel

Location:
Greater New York City Area
Industry:
Apparel & Fashion


Peter T Scardino Photo 3
Peter T Scardino, New York NY

Peter T Scardino, New York NY

Specialties:
Urology, Surgery
Work:
Memorial Sloan-Kettering
1275 York Ave, New York, NY 10065
Education:
Duke University(1971)


Peter Scardino Photo 4
Nomograms To Aid In The Treatment Of Prostatic Cancer

Nomograms To Aid In The Treatment Of Prostatic Cancer

US Patent:
6409664, Jun 25, 2002
Filed:
Nov 24, 1999
Appl. No.:
09/444706
Inventors:
Michael W. Kattan - New York NY 10021
Peter T. Scardino - New York NY 10021
International Classification:
A61B 500
US Classification:
600300, 128898
Abstract:
This invention relates to methods and apparatus for predicting probability of cancer recurrence following radical prostatectomy using predetermined clinical and pathological factors. The invention includes nomograms which can be used preoperatively and postoperatively in patients diagnosed with prostatic adenocarcinoma to aid in selection of an appropriate course of therapy.


Peter Scardino Photo 5
Method To Determine Outcome For Patients With Prostatic Disease

Method To Determine Outcome For Patients With Prostatic Disease

US Patent:
2003023, Dec 25, 2003
Filed:
Mar 14, 2003
Appl. No.:
10/389245
Inventors:
Kevin Slawin - Houston TX, US
Shahrokh Shariat - Dallas TX, US
Michael Kattan - New York NY, US
Peter Scardino - Manhattan NY, US
Assignee:
Baylor College of Medicine (by Slawin and Shariat)
International Classification:
C12Q001/70
US Classification:
435/005000
Abstract:
A method for prognosis of patients with prostate cancer, e.g., clinically localized prostate cancer, is provided.


Peter Scardino Photo 6
Peter Scardino

Peter Scardino

Location:
Greater New York City Area
Industry:
Textiles